Viela Bio to Webcast Third Quarter 2020 Financial Results and Program Highlights on November 10, 2020
Viela Bio (Nasdaq: VIE) will host a webcast and conference call on November 10, 2020, at 5:00 p.m. EST to discuss its third-quarter 2020 financial results and program highlights.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Viela Bio (Nasdaq: VIE) will host a webcast and conference call on November 10, 2020, at 5:00 p.m. EST to discuss its third-quarter 2020 financial results and program highlights. The event will be accessible via the company's Events & Presentations page, with participation available through specified phone numbers.
Details
News Market Reaction – VIE
The recorded move for VIE in the trading session of this news was +3.64%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
GAITHERSBURG, Md., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Viela Bio (Nasdaq:VIE), a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for autoimmune and severe inflammatory diseases, today announced it will host a webcast and conference call on Tuesday, November 10, 2020 at 5:00 p.m. EST to discuss its third quarter 2020 financial results and program highlights.
The webcast will be accessible on the Events & Presentations page of the Company’s website. Individuals can participate in the conference call by dialing (877) 783-8848 (domestic) or (631) 350-0960 (international) and referring to conference ID #: 1237908. The archived webcast will be available for replay on the Viela Bio website approximately two hours after the event.
About Viela Bio
Viela Bio, headquartered in Gaithersburg, Maryland, is a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for autoimmune and severe inflammatory diseases. For more information, please visit www.vielabio.com.
Source: Viela Bio
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.